Diagnostic value of nucleic-acid-sequence-based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients

Intervirology

Volumn 42, Issue 5-6, 1999, Pages 373-381

  Goossens, Valère J ^a   Blok, Marinus J ^a   Christiaans, Maarten H L ^a   Van Hooff, Johannes P ^a   Sillekens, Peter ^c   Hockerstedt K ^b   Lautenschlager, Irmeli ^b   Middeldorp, Jaap M ^c   Bruggeman, Cathrien A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Organon Teknika   (Netherlands)

Author keywords

Antigenemia; CMV; mRNA Immediate early gene products; PCR; pp67; Screening

Indexed keywords

MESSENGER RNA;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; GENE AMPLIFICATION; HUMAN; KIDNEY GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; VIRUS CULTURE;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0342680019     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053974     Document Type: Conference Paper

References (22)

1. Britt WJ, Alford CA: Cytomegalovirus; in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. New York, Lippincott-Raven, 1996, pp 2493-2523.
2. Patel R, Snydman DR, Rubin RH, Ho M, Pescovitz M, Martin M, Paya CV: Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996;61:1279-1289.
3. Blok MJ, Goossens VJ, Vanherle SJV, Top B, Tacken N, Middeldorp JM, Christiaans MH, Van Hooff J, Bruggeman CA: Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification. J Clin Microbiol 1998;36:1341-1346.
4. Blok MJ, Christiaans MHL, Goossens VJ, Van Hooff JP, Sillekens P, Middeldorp JM, Bruggeman CA: Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification. Transplantation 1999;67:1274-1277.
5. Goossens VJ, Blok MJ, Christiaans MHL, Sillekens P, Middeldorp JM, Bruggeman CA: Early detection of cytomegalovirus in renal transplant recipients: Comparison of PCR. NASBA, pp65-antigenemia and viral culture. Transplant Proc. in press.
6. Van der Bij W, Schirm J, Torensma R, Van Son WJ, Tegzess AM. The TH: Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol 1988;26:2531-2535.
7. Kraat YJ, Christiaans MHL, Nieman FHM, van den Berg-Loonen PM, van Hooff JP, Bruggeman CA: Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy. Transplant Int 1994;7:362-367.
8. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noordaa J: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
9. Reina J, Saurina J, Fernandez-Baea V, Blanco I, Munar M: An increase in the number of polymorphonuclear leukocytes inoculated on shellvial culture increases the sensitivity of this assay in the detection of cytomegalovirus in the blood of immunocompromised patients. Diagn Microbiol Infect Dis 1998;31:425-428.
10. Roberts TC, Buller RS, Gaudreault-Keener M, Sternhell KE, Garlock K, Singer GG, Brennan DC, Storch GA: Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCR. J Clin Microbiol 1997;35:2224-2228.
11. The TK, Harmsen MC, Van der Bij W, Van den Berg AP, Van Son WJ: Relationship between monitoring the viral load in blood, human cytomegalovirus pathophysiology and management strategies of patients after transplantation. Monogr Virol. Basel. Karger, 1998, vol 21, pp 270-279.
12. The TH, Van den Berg AP, Harmsen MC, Van der Bij W, Van Son WJ: The cytomegalovirus antigenemia assay: A plea for standardization. Scand J Infect Dis 1995;suppl 99:25-29.
13. Sharma AK, Taylor JD, Tong W, Brown MW, Sells RA, Bakran A: Utility of the pp65 direct antigenemia test in the diagnosis of cytomegalovirus (CMV) in renal transplant recipients. Transplant Proc 1997;29:799.
14. Gerna G, Baldanti F, Middeldorp JM, Furione M, Zavattoni M, Lilleri D, Revello MG: Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification. J Clin Microbiol 1999;37:902-911.
15. Grefte JM, Van der Gun BT, Schmolke S, Van der Giessen M, Van Son WJ, Plachter B, Jahn G, The TH: The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol 1992;73:2923-2932.
16. Reagen KJ, Cabradilla C, Shuman B, Stollar N, Laudemann J, Bai X, Hosler G, Scheuermann RH: Analytical performance of a quantitative CMV DNA detection method. Monogr Virol. Basel, Karger. 1998, vol 21, pp 252-261.
17. Middeldorp J: Direct quantification of human cytomegalovirus (HCMV) immediate early and late mRNA levels in the blood of HCMV-infected individuals using competitive NASBA (abstract G0-21) 7th Int Cytomegalovirus Workshop, Brighton, April 1999. J Clin Virol 1999;12:103.
18. Rubin RH: Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12(suppl 7):S754-S766.
19. Lautenschlager I: Role of cytomegalovirus infection in the process of organ allograft rejection. Monogr Virol. Basel, Karger, 1998, vol 21, pp 142-157.
20. Grundy JE: Current antiviral therapy fails to prevent the pro-inflammatory effects of cytomegalovirus infection, whilst rendering infected cells relatively resistant to immune attack. Monogr Virol. Basel. Karger, 1998. vol 21, pp 67-89.
21. Miller DM, Sedmak DD: Cytomegalovirus persistence: escape from cell-mediated immunosurveillance. Monogr Virol. Basel, Karger, 1998, vol 21, pp 1-11.
22. Fujinami RS, Nelson JA, Walker L, Oldstone MBA: Sequence homology and immunologic crossreactivity of human cytomegalovirus with HLA-DR chain: A means for graft rejection and immunosuppression. J Virol 1988;62:100-105.